9 articles for thisTarget

---

The following articles (labelled with PubMed ID or TBD) are for your review

PMID	Data	Article Title	Organization
28129980	4	Discovery of furan carboxylate derivatives as novel inhibitors of ATP-citrate lyase via virtual high-throughput screening.	Harvard Medical School
27997879	15	Design and synthesis of emodin derivatives as novel inhibitors of ATP-citrate lyase.	Harvard Medical School
21726077	51	The lipogenesis pathway as a cancer target.	Wayne State University
17521912	15	The biology and chemistry of hyperlipidemia.	Sinhgad College of Pharmacy
17383874	15	2-hydroxy-N-arylbenzenesulfonamides as ATP-citrate lyase inhibitors.	Bristol-Myers Squibb Pharmaceutical Research Institute
31532203	24	Cinerols, Nitrogenous Meroterpenoids from the Marine Sponge	Shanghai Jiao Tong University
9733484	39	ATP-Citrate lyase as a target for hypolipidemic intervention. 2. Synthesis and evaluation of (3R,5S)-omega-substituted-3-carboxy-3, 5-dihydroxyalkanoic acids and their gamma-lactone prodrugs as inhibitors of the enzyme in vitro and in vivo.	Smithkline Beecham Pharmaceuticals
8784456	55	ATP-citrate lyase as a target for hypolipidemic intervention. Design and synthesis of 2-substituted butanedioic acids as novel, potent inhibitors of the enzyme.	Smithkline Beecham Pharmaceuticals
30195238	26	ATP citrate lyase (ACLY) inhibitors: An anti-cancer strategy at the crossroads of glucose and lipid metabolism.	University of Pisa